SE7905972L - Forfarande for framstellning av magsyraneutraliserande medel, magsyraneutraliserande medel, samt metod for behandling av hyperaciditet och dermed relaterande sjukdomstillstand - Google Patents

Forfarande for framstellning av magsyraneutraliserande medel, magsyraneutraliserande medel, samt metod for behandling av hyperaciditet och dermed relaterande sjukdomstillstand

Info

Publication number
SE7905972L
SE7905972L SE7905972A SE7905972A SE7905972L SE 7905972 L SE7905972 L SE 7905972L SE 7905972 A SE7905972 A SE 7905972A SE 7905972 A SE7905972 A SE 7905972A SE 7905972 L SE7905972 L SE 7905972L
Authority
SE
Sweden
Prior art keywords
gastric acid
neutralizing agents
procedure
preparation
related disease
Prior art date
Application number
SE7905972A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Inventor
E K Byrod
J A Sjogren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Priority to SE7905972A priority Critical patent/SE7905972L/
Priority to EP80850081A priority patent/EP0022429B1/de
Priority to AT80850081T priority patent/ATE1968T1/de
Priority to DE8080850081T priority patent/DE3061333D1/de
Priority to PH24163A priority patent/PH16372A/en
Priority to AU59734/80A priority patent/AU535403B2/en
Priority to NZ194165A priority patent/NZ194165A/en
Priority to FI802139A priority patent/FI71058C/fi
Priority to NO802030A priority patent/NO152892C/no
Priority to DK290080A priority patent/DK154265C/da
Priority to PT71503A priority patent/PT71503B/pt
Priority to GR62397A priority patent/GR69623B/el
Priority to IE1402/80A priority patent/IE50141B1/en
Priority to ES493187A priority patent/ES8106835A1/es
Priority to CA000355688A priority patent/CA1146860A/en
Priority to JP9281580A priority patent/JPS5618922A/ja
Publication of SE7905972L publication Critical patent/SE7905972L/
Priority to PH26541A priority patent/PH16705A/en
Priority to US06/338,302 priority patent/US4465667A/en
Priority to AR22885483D priority patent/AR228854A1/es
Priority to SG93/84A priority patent/SG9384G/en
Priority to HK434/84A priority patent/HK43484A/en
Priority to MY445/85A priority patent/MY8500445A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE7905972A 1979-07-09 1979-07-09 Forfarande for framstellning av magsyraneutraliserande medel, magsyraneutraliserande medel, samt metod for behandling av hyperaciditet och dermed relaterande sjukdomstillstand SE7905972L (sv)

Priority Applications (22)

Application Number Priority Date Filing Date Title
SE7905972A SE7905972L (sv) 1979-07-09 1979-07-09 Forfarande for framstellning av magsyraneutraliserande medel, magsyraneutraliserande medel, samt metod for behandling av hyperaciditet och dermed relaterande sjukdomstillstand
EP80850081A EP0022429B1 (de) 1979-07-09 1980-06-06 Verfahren zur Herstellung von Substanzen zur Neutralisierung der Magensäure und Substanzen zur Neutralisierung der Magensäure
AT80850081T ATE1968T1 (de) 1979-07-09 1980-06-06 Verfahren zur herstellung von substanzen zur neutralisierung der magensaeure und substanzen zur neutralisierung der magensaeure.
DE8080850081T DE3061333D1 (en) 1979-07-09 1980-06-06 Process for the preparation of gastric acid neutralizing agents and gastric acid neutralizing agents
PH24163A PH16372A (en) 1979-07-09 1980-06-18 Gastric acid neutralizing suspension
AU59734/80A AU535403B2 (en) 1979-07-09 1980-06-27 Antacid& aluminium hydroxide suspension
NZ194165A NZ194165A (en) 1979-07-09 1980-06-27 Antacidaqueous suspension containing aluminium hydroxide
FI802139A FI71058C (fi) 1979-07-09 1980-07-03 Foerfarande foer framstaellning av en magsyraneutraliserande suspension
NO802030A NO152892C (no) 1979-07-09 1980-07-04 Fremgangsmaate til fremstilling av en vandig mavesyre-noeytraliserende suspensjon.
DK290080A DK154265C (da) 1979-07-09 1980-07-04 Fremgangsmaade til stabilisering af en vandig mavesyreneutraliserende suspension
GR62397A GR69623B (de) 1979-07-09 1980-07-07
PT71503A PT71503B (en) 1979-07-09 1980-07-07 Process for the preparation of gastric acid neutralizing agentsand method for treating hyper acidity and disorders related thereto
IE1402/80A IE50141B1 (en) 1979-07-09 1980-07-07 Process for the preparation of gastric acid neutralizing agents and gastric acid neutralizing agents
ES493187A ES8106835A1 (es) 1979-07-09 1980-07-08 Procedimiento para la preparacion de una composicion acuosa neutralizadora del acido gastrico.
CA000355688A CA1146860A (en) 1979-07-09 1980-07-08 Process for the preparation of gastric acid neutralizing agents, gastric acid neutralizing agents, and a method for treating hyper acidity and disorders related thereto
JP9281580A JPS5618922A (en) 1979-07-09 1980-07-09 Gastric acid neutraizing agent and its manufacture
PH26541A PH16705A (en) 1979-07-09 1981-11-27 Method for treating hyperacidity and disorders related thereto
US06/338,302 US4465667A (en) 1979-07-09 1982-01-11 Process for the preparation of gastric acid neutralizing agents, gastric acid neutralizing agents, and a method for treating hyperacidity and disorders related thereto
AR22885483D AR228854A1 (es) 1979-07-09 1983-01-01 Procedimiento para la preparacion de agentes neutralizantes de acido gastrico
SG93/84A SG9384G (en) 1979-07-09 1984-02-04 Process for the preparation of gastric acid neutralizing agents and gastric acid neutralizing agents
HK434/84A HK43484A (en) 1979-07-09 1984-05-17 Process for the preparation of gastric acid neutralizing agents and gastric acid neutralizing agents
MY445/85A MY8500445A (en) 1979-07-09 1985-12-30 Process for the preparation of gastric acid neutralizing agents and gastric acid neutralizing agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7905972A SE7905972L (sv) 1979-07-09 1979-07-09 Forfarande for framstellning av magsyraneutraliserande medel, magsyraneutraliserande medel, samt metod for behandling av hyperaciditet och dermed relaterande sjukdomstillstand

Publications (1)

Publication Number Publication Date
SE7905972L true SE7905972L (sv) 1981-01-10

Family

ID=20338481

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7905972A SE7905972L (sv) 1979-07-09 1979-07-09 Forfarande for framstellning av magsyraneutraliserande medel, magsyraneutraliserande medel, samt metod for behandling av hyperaciditet och dermed relaterande sjukdomstillstand

Country Status (21)

Country Link
US (1) US4465667A (de)
EP (1) EP0022429B1 (de)
JP (1) JPS5618922A (de)
AR (1) AR228854A1 (de)
AT (1) ATE1968T1 (de)
AU (1) AU535403B2 (de)
CA (1) CA1146860A (de)
DE (1) DE3061333D1 (de)
DK (1) DK154265C (de)
ES (1) ES8106835A1 (de)
FI (1) FI71058C (de)
GR (1) GR69623B (de)
HK (1) HK43484A (de)
IE (1) IE50141B1 (de)
MY (1) MY8500445A (de)
NO (1) NO152892C (de)
NZ (1) NZ194165A (de)
PH (2) PH16372A (de)
PT (1) PT71503B (de)
SE (1) SE7905972L (de)
SG (1) SG9384G (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0642001B2 (ja) * 1983-10-20 1994-06-01 セイコーエプソン株式会社 合成樹脂製レンズ
JPS6486101A (en) * 1987-06-18 1989-03-30 Toray Industries Production of antireflecting article
JPH0696536B2 (ja) * 1988-02-26 1994-11-30 佐藤製薬株式会社 制酸剤含有内用懸濁液
US5158770A (en) * 1989-12-29 1992-10-27 Freund Industrial Co., Ltd. Aqueous solution containing ginkgo leaf extract
AU657882B2 (en) * 1993-03-26 1995-03-23 Wallace Victor Wind Improvements in or relating to the treatment of diarrhoea
US5360793A (en) * 1993-05-24 1994-11-01 Sterling Winthrop Inc. Rafting antacid formulation
SE509300C2 (sv) * 1995-02-02 1999-01-11 Sueddeutsche Kalkstickstoff Katjoniskt dispergerade aluminiumhydroxiduppslamningar
US5569466A (en) * 1995-05-17 1996-10-29 R. P. Scherer Corporation Fill compositions for soft elastic gel capsules
US6187317B1 (en) 1999-07-14 2001-02-13 Judith Taylor Natural anti-diarrheal composition and method
ES2278115T3 (es) * 2003-10-13 2007-08-01 Zoser B. Nat.Rer.Dr. Salama Composicion farmaceutica que comprende oxoplatino y sus sales.
US20060073202A1 (en) * 2004-10-05 2006-04-06 Rocca Jose G Dual component medicament delivery system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2211745A (en) * 1940-04-18 1940-08-13 Alba Pharmaceutical Company In Compound of aluminum hydroxide and process of making the same
US2999790A (en) * 1959-08-24 1961-09-12 Sterling Drug Inc Stable aluminum hydroxide suspension
US3239416A (en) * 1963-05-29 1966-03-08 Armour Pharma Aluminum hydroxide-metal hydroxide antacid and process of making the same
US3272704A (en) * 1963-06-06 1966-09-13 Armour Pharma Stable aluminum hydroxide-magnesium compound codried gel antacids and process of making the same
US3499963A (en) * 1964-04-15 1970-03-10 Armour Pharma Codried aluminum hydroxide-aluminum chelate antacid
US3350266A (en) * 1964-06-04 1967-10-31 Bristol Myers Co Antacid composition comprising aluminum hydroxide, magnesium hydroxide and magnesium gluconate
GB1269987A (en) * 1968-04-18 1972-04-12 Garland Richard Brown Antacid composition
US3599150A (en) * 1969-08-01 1971-08-10 Miles Lab Stabilized aluminum hydroxide suspensions
GB1414121A (en) * 1971-09-15 1975-11-19 Smith W J Antacid composition and its preparation
US3873694A (en) * 1973-09-27 1975-03-25 Cpc International Inc Direct compression tabletting composition and pharmaceutical tablets produced therefrom

Also Published As

Publication number Publication date
FI71058C (fi) 1986-11-24
CA1146860A (en) 1983-05-24
AR228854A1 (es) 1983-04-29
ES493187A0 (es) 1981-09-01
JPS6411008B2 (de) 1989-02-23
AU5973480A (en) 1981-01-15
GR69623B (de) 1982-07-06
FI71058B (fi) 1986-08-14
PH16372A (en) 1983-09-14
PT71503B (en) 1981-12-11
HK43484A (en) 1984-05-25
MY8500445A (en) 1985-12-31
DK154265C (da) 1989-03-28
JPS5618922A (en) 1981-02-23
NZ194165A (en) 1984-07-06
AU535403B2 (en) 1984-03-22
NO152892B (no) 1985-09-02
DE3061333D1 (en) 1983-01-20
PH16705A (en) 1984-01-20
ATE1968T1 (de) 1982-12-15
PT71503A (en) 1980-08-01
DK290080A (da) 1981-01-10
US4465667A (en) 1984-08-14
FI802139A7 (fi) 1981-01-10
EP0022429B1 (de) 1982-12-15
EP0022429A1 (de) 1981-01-14
NO802030L (no) 1981-01-12
ES8106835A1 (es) 1981-09-01
IE50141B1 (en) 1986-02-19
IE801402L (en) 1981-01-09
NO152892C (no) 1985-12-11
DK154265B (da) 1988-10-31
SG9384G (en) 1985-02-15

Similar Documents

Publication Publication Date Title
DE69525444T2 (de) Verfahren zur herstellung von biologisch aktiven siliziumverbindungen in konzentrierter form
DE69532858T2 (de) Verfahren zur stabilisierung von gelatine-produkten
US3965261A (en) Method for treating papillomas
SE7905972L (sv) Forfarande for framstellning av magsyraneutraliserande medel, magsyraneutraliserande medel, samt metod for behandling av hyperaciditet och dermed relaterande sjukdomstillstand
SE8303531D0 (sv) Farmaceutisk komposition
BG42000A3 (en) Method for preparing suspension of microcapsulated bacampicilline salt of acid incorporation
ATE5125T1 (de) Pharmazeutische zusammensetzung, die sanguinaria und galangal enthaelt, zur behandlung von periodontitis und tumoren.
BR8804076A (pt) Composicao alcoolica apropriada para aplicacao topica a pele humana e processo para a preparacao de uma composicao alcoolica
SE7614258L (sv) Forfarande for framstellning av kinazoloderivat
DE3382087D1 (de) Praeparate zur behandlung von wunden der hautoberflaeche und verfahren zur herstellung derartiger praeparate.
NO157145C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive n-glykosylerte karboksylsyreamidderivater.
IL58299A (en) Fluorine-containing 1,4-dihydropyridine derivatives,their production and their medicinal use
SE451666B (sv) Stabil bensoylperoxidkomposition
DE3361990D1 (en) Alkylene-bridged guanidino-thiazole derivatives, method for their preparation and their use as medicaments
PT71408A (de) Verfahren zur herstellung von 1-alkadien-2,4-yl-2-hidroxymethyl-3,4,5-trimydroxypiperidinen mit wirkung uber die kohlehydraten und/oder fettwechsel und von diesen verbindungen enthaltenden pharmazeutischen und/oder tierartzleichen praparaten
ATA379182A (de) Verfahren zur herstellung von presslingen mit retardierter wirkstofffreisetzung
PT76303B (en) Process for the preparation of pesticidal compositions containing the active substance in a aqueous vehicle
DE3063525D1 (en) Process for the preparation of phosphono-hydroxy-acetic acid and salts thereof and autiviral compositions containing them
US4703041A (en) D-glucuronic acid-urea condensate preparation for smoothing human skin
ZA814523B (en) Salt of furosemide or piretanide as the acid component and penbutolol or (-).3-(4)-(3-(3,4-dimethoxyphenylethylamino)-2-hydroxy-proposy)-phenyl)crotononitrile as the base component,process for its prepration,composition in which it is present and its use
KR880004810A (ko) 소화성 궤양 치료제
ATE3033T1 (de) Derivate des 2-hydroxymethyl-3,4,5-trihydroxypiperidins, ihre herstellung und sie enthaltende arzneimittel.
ATE1442T1 (de) Pharmazeutisches mittel, enthaltend all-e- oder 13-z-7,8-dehydro-retinsaeure und verfahren zu seiner herstellung.
ATE9957T1 (de) Verfahren zur herstellung eines umhuellten acetylsalicylsaeurepraeparates.
PT77285A (en) Process for preparing substituted benzenosulphonates and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7905972-1

Format of ref document f/p: F